gammaCore Device for Chronic Posttraumatic Headache Pain Management in Veterans With Comorbid Mood Disorders: A Case Report.
Following initiation of gammaCore therapy, the patient experienced a marked reduction in headache intensity and frequency, alongside significant improvements in anxiety levels. These outcomes suggest that gammaCore may be a promising noninvasive treatment option for CPTHA, particularly in patients with coexisting mood disorders. Further research is warranted to validate these findings and establish gammaCore's role in CPTHA management.
Authors
- Jason Parmar (ORCID: https://orcid.org/0009-0000-4876-8850)
- Darlene D. Makulski
Institutions
- Michael E. DeBakey VA Medical Center (US)
- Baylor College of Medicine (US)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- Primary Topic
- Anesthesia and Pain Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00